Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-04

FDA Approved: AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for a generic fixed-dose combination of amlodipine and benazepril hydrochloride, enabling continued marketing of the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine and Benazepril Hydrochloride (Amlodipine and Benazepril Hydrochloride)

Snippet

SUPPL AP for AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE (AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE)